Jump to navigation Jump to search

WikiDoc Resources for AGG01


Most recent articles on AGG01

Most cited articles on AGG01

Review articles on AGG01

Articles on AGG01 in N Eng J Med, Lancet, BMJ


Powerpoint slides on AGG01

Images of AGG01

Photos of AGG01

Podcasts & MP3s on AGG01

Videos on AGG01

Evidence Based Medicine

Cochrane Collaboration on AGG01

Bandolier on AGG01


Clinical Trials

Ongoing Trials on AGG01 at Clinical

Trial results on AGG01

Clinical Trials on AGG01 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on AGG01

NICE Guidance on AGG01


FDA on AGG01

CDC on AGG01


Books on AGG01


AGG01 in the news

Be alerted to news on AGG01

News trends on AGG01


Blogs on AGG01


Definitions of AGG01

Patient Resources / Community

Patient resources on AGG01

Discussion groups on AGG01

Patient Handouts on AGG01

Directions to Hospitals Treating AGG01

Risk calculators and risk factors for AGG01

Healthcare Provider Resources

Symptoms of AGG01

Causes & Risk Factors for AGG01

Diagnostic studies for AGG01

Treatment of AGG01

Continuing Medical Education (CME)

CME Programs on AGG01


AGG01 en Espanol

AGG01 en Francais


AGG01 in the Marketplace

Patents on AGG01

Experimental / Informatics

List of terms related to AGG01

AGG01 is the tentative name of a new Penicillin-class antibiotic, recently discovered in the breast milk[1] of the Tammar Wallaby, reportedly one hundred times more powerful than penicillin.

This compound was found to be effective against MRSA, E. coli, Streptococci, Salmonella, Bacillus subtilis, Pseudomonas spp., Proteus vulgaris, and Staphylococcus aureus.

AGG01 has not yet been classified as a Beta-lactam antibiotic.

AGG01 is a cationic peptide, which is a polycationic protein which is rich in positive residues of the amino acidss arginine and lysine, and which folds into an amphipathic structure (one which has both hydrophobic and hydrophilic areas). These features mean that it can interact with the anionic lipids in the bacterial membrane, such as phosphatidylglycerol. It inserts itself into the membrane, by competing with cross-linking proteins between each membrane layer, and then sets up trans-membrane protein channels which induce ion transport out of the cell. This causes huge leakage via osmosis through these 'pores’ and the general consensus is that the loss of these essential molecules is the mechanism by which bacteria are killed. The bacterial membrane has a different structure from the mammalian plasma membrane, so the protein can only kill pathogenic cells and not human ones.


  1. "Fighting superbugs with milk". 2006-04-20. Retrieved 2006-09-07. Check date values in: |date= (help); External link in |work= (help)

Template:WH Template:WikiDoc Sources